These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 27569208)

  • 1. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
    Cheng P; Wang J; Waghmare I; Sartini S; Coviello V; Zhang Z; Kim SH; Mohyeldin A; Pavlyukov MS; Minata M; Valentim CL; Chhipa RR; Bhat KP; Dasgupta B; La Motta C; Kango-Singh M; Nakano I
    Cancer Res; 2016 Dec; 76(24):7219-7230. PubMed ID: 27569208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
    Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF
    Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
    Mao P; Joshi K; Li J; Kim SH; Li P; Santana-Santos L; Luthra S; Chandran UR; Benos PV; Smith L; Wang M; Hu B; Cheng SY; Sobol RW; Nakano I
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8644-9. PubMed ID: 23650391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
    Chen Z; Wang HW; Wang S; Fan L; Feng S; Cai X; Peng C; Wu X; Lu J; Chen D; Chen Y; Wu W; Lu D; Liu N; You Y; Wang H
    J Clin Invest; 2019 Apr; 129(5):2043-2055. PubMed ID: 30958800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
    Yin J; Oh YT; Kim JY; Kim SS; Choi E; Kim TH; Hong JH; Chang N; Cho HJ; Sa JK; Kim JC; Kwon HJ; Park S; Lin W; Nakano I; Gwak HS; Yoo H; Lee SH; Lee J; Kim JH; Kim SY; Nam DH; Park MJ; Park JB
    Cancer Res; 2017 Sep; 77(18):4973-4984. PubMed ID: 28754668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles from High-Grade Glioma Exchange Diverse Pro-oncogenic Signals That Maintain Intratumoral Heterogeneity.
    Ricklefs F; Mineo M; Rooj AK; Nakano I; Charest A; Weissleder R; Breakefield XO; Chiocca EA; Godlewski J; Bronisz A
    Cancer Res; 2016 May; 76(10):2876-81. PubMed ID: 27013191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP21 promotes self-renewal and tumorigenicity of mesenchymal glioblastoma stem cells by deubiquitinating and stabilizing FOXD1.
    Zhang Q; Chen Z; Tang Q; Wang Z; Lu J; You Y; Wang H
    Cell Death Dis; 2022 Aug; 13(8):712. PubMed ID: 35974001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
    Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
    Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma.
    Song Y; Jiang Y; Tao D; Wang Z; Wang R; Wang M; Han S
    Neuro Oncol; 2020 Jan; 22(1):46-57. PubMed ID: 31400279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PGI-KLF4 pathway regulates self-renewal of glioma stem cells residing in the mesenchymal niches in human gliomas.
    Zhu XY; Wang L; Luan SH; Zhang HS; Huang WT; Wang NH
    Neoplasma; 2014; 61(4):401-10. PubMed ID: 24645841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion.
    Zhang W; Liu Y; Hu H; Huang H; Bao Z; Yang P; Wang Y; You G; Yan W; Jiang T; Wang J; Zhang W
    PLoS One; 2015; 10(11):e0142856. PubMed ID: 26575197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.
    Shao C; Sullivan JP; Girard L; Augustyn A; Yenerall P; Rodriguez-Canales J; Liu H; Behrens C; Shay JW; Wistuba II; Minna JD
    Clin Cancer Res; 2014 Aug; 20(15):4154-66. PubMed ID: 24907115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of ALDH1A3 might independently influence poor progression-free and overall survival in patients with glioma via maintaining glucose uptake and lactate production.
    Ni W; Xia Y; Luo L; Wen F; Hu D; Bi Y; Qi J
    Cell Biol Int; 2020 Feb; 44(2):569-582. PubMed ID: 31642564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UCHL3 induces radiation resistance and acquisition of mesenchymal phenotypes by deubiquitinating POLD4 in glioma stem cells.
    Fan L; You H; Jiang X; Niu Y; Chen Z; Wang H; Xu Y; Zhou P; Wei L; Jiang T; Deng D; Xue L; Peng Y; Xing W; Shao N
    Cell Mol Life Sci; 2024 Jun; 81(1):247. PubMed ID: 38829550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells.
    Chen Z; Wang H; Zhang Z; Xu J; Qi Y; Xue H; Gao Z; Zhao R; Wang S; Zhang S; Qiu W; Guo X; Li G
    J Exp Clin Cancer Res; 2021 Jan; 40(1):20. PubMed ID: 33413577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.
    Chandran UR; Luthra S; Santana-Santos L; Mao P; Kim SH; Minata M; Li J; Benos PV; DeWang M; Hu B; Cheng SY; Nakano I; Sobol RW
    Genom Data; 2015 Sep; 5():333-336. PubMed ID: 26251826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
    Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
    Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth.
    Haynes HR; Scott HL; Killick-Cole CL; Shaw G; Brend T; Hares KM; Redondo J; Kemp KC; Ballesteros LS; Herman A; Cordero-Llana O; Singleton WG; Mills F; Batstone T; Bulstrode H; Kauppinen RA; Wurdak H; Uney JB; Short SC; Wilkins A; Kurian KM
    J Pathol; 2019 Apr; 247(4):422-434. PubMed ID: 30565681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.